Article Menu
Need Help?
No Article Versions Notes Found
Cite
Parulekar, W.R.; McKenzie, M.; Chi, K.N.; Klotz, L.; Catton, C.; Brundage, M.; Ding, K.; Hiltz, A.; Meyer, R.; Saad, F. Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group. Curr. Oncol. 2008, 15, 179-184. https://doi.org/10.3747/co.v15i4.257
Parulekar WR, McKenzie M, Chi KN, Klotz L, Catton C, Brundage M, Ding K, Hiltz A, Meyer R, Saad F. Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group. Current Oncology. 2008; 15(4):179-184. https://doi.org/10.3747/co.v15i4.257
Chicago/Turabian StyleParulekar, W.R., M. McKenzie, K.N. Chi, L. Klotz, C. Catton, M. Brundage, K. Ding, A. Hiltz, R. Meyer, and F. Saad. 2008. "Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group" Current Oncology 15, no. 4: 179-184. https://doi.org/10.3747/co.v15i4.257
APA StyleParulekar, W. R., McKenzie, M., Chi, K. N., Klotz, L., Catton, C., Brundage, M., Ding, K., Hiltz, A., Meyer, R., & Saad, F. (2008). Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group. Current Oncology, 15(4), 179-184. https://doi.org/10.3747/co.v15i4.257
